SBIR/STTR Research Award

Fast and Simple Real Time PCR for Quantitative Molecular Diagnostic Testing

Award identifier df480e89190511c4432a8788a30c41afb64d812e44727e1c5627048de6e4d75cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$120,411

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
THERMAL GRADIENT, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Real time quantitative PCR is rapidly replacing conventional or end-point PCR as a major diagnostic tool. Thermal Gradient Inc. (TG) has already shown that microfluidic devices based on its proprietary technology can carry out end-point PCR quickly and simply for bio-defense applications. Quickly is understood to mean reactions completed in minutes instead of hours, as with conventional equipment. TG would like to extend the benefits of its technology into quantitat ive diagnostic testing. The proposed project, Fast and Simple Real Time PCR for Diagnostic Testing, is intended to establish the feasibility of performing real time PCR more rapidly and conveniently than conventional means. The product envisioned here wo uld be a compact instrument that could be used in the operating room or at the bedside to determine, among other applications, the microbial load in body fluids or the extent of tumor invasion in a biopsy, all within 30 minutes of sample collection. All of the technology required to carry this out exists today except for rapid, real-time PCR thermal cycling. In end-point PCR for bio-defense, the reaction is carried out to completion and then fluorescent detection is employed to identify from the amplified DNA which among many possible pathogens have been employed in an attack. In real-time PCR the objective is to determine from the rate of the reaction the starting concentration of usually one pathogen or a mutant sequence, although detection of multiple targets is also possible. This requires fluorescent detection of the reaction mix while it is undergoing PCR. In this Phase I application, we propose to achieve two aims: 1. Show that a realtime version of the TG device, one that permits observing the s ample mix as it flows through the device, will still carry out an end-point PCR; and 2. Show that it is reasonable to expect that a well designed detection system will be able to detect the fluorescent signal that will be emitted by the real-time devic e. If these goals are met it is very likely that real time PCR can be carried out successfully in a Phase II project meant to demonstrate all the pieces of a very fast, complete, and quantitative molecular diagnostic system.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.